p. 1−1
2357-0695
Vol.14/No.1
p. 2−5
2357-0695
Vol.14/No.1
demonstrated a significant deterioration in their final QoL scores compared to baseline. IMRT had an incremental cost of5912 USD per patient with an incremental effectiveness of 4 months of PFS, providing an ICER of 6.260.Conclusion: Although it may be associated with longer PFS, IMRT in MPM with intact lung is likely detrimental and notcost-effective.]]>
p. 6−11
2357-0695
Vol.14/No.1
p. 12−16
2357-0695
Vol.14/No.1
p. 17−20
2357-0695
Vol.14/No.1
p. 21−28
2357-0695
Vol.14/No.1
p. 29−33
2357-0695
Vol.14/No.1
p. 34−38
2357-0695
Vol.14/No.1
p. 39−42
2357-0695
Vol.14/No.1
p. 43−46
2357-0695
Vol.14/No.1
p. 47−49
2357-0695
Vol.14/No.1